Patents by Inventor Jonathan Herskovitz

Jonathan Herskovitz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LIPID NANOPARTICLE FORMULATIONS AND METHODS OF USE THEREOF
    Publication number: 20240165266
    Abstract: Disclosed herein are methods and compositions for lipid nanoparticles encapsulating a nucleic acid encoding for a CRISPR nucleic acid complementary to a HIV-1 gene. Also disclosed are lipid nanoparticle compositions, nucleotides, cells, and methods associated with the compositions.
    Type: Application
    Filed: March 17, 2022
    Publication date: May 23, 2024
    Inventors: Howard E. Gendelman, Jonathan Herskovitz, Mahmudul Hasan, Bhavesh Kevadiya, Milankumar Patel
  • CRISPR/CAS9 SYSTEM FOR MULTISTRAIN HIV-1 TREATMENT
    Publication number: 20230122226
    Abstract: Nucleic acids for use in CRISPR systems for treating HIV infections are disclosed. Pharmaceutical compositions incorporating the nucleic acids are disclosed as are methods of treating HIV using the nucleic acids.
    Type: Application
    Filed: March 5, 2021
    Publication date: April 20, 2023
    Inventors: Howard Gendelman, Jonathan Herskovitz, Mahmudul Hasan
  • VIRUS-LIKE PARTICLES AND METHODS OF USE THEREOF
    Publication number: 20220194990
    Abstract: The present invention provides virus-like particles and methods of manufacture and use thereof. In accordance with the instant invention, virus-like particles (VLPs), particularly human immunodeficiency virus (HIV) VLPs, are provided. The HIV VLPs comprise at least one HIV structural protein and the HIV envelope protein, but lacks the HIV genome and lacks functional reverse transcriptase and integrase.
    Type: Application
    Filed: January 31, 2020
    Publication date: June 23, 2022
    Inventors: Howard E. Gendelman, Jonathan Herskovitz, Mahmudul Hasan, Bhavesh Kevadiya